United States Generic Drug Market Report 2018-2023 - ResearchAndMarkets.com

DUBLIN--()--The "US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.

This US Generic Drug Market report provides a comprehensive insight into the historical and current trends as well as the future prospects of the generic drug market in the United States.

The US generic drug market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States.

During 2011-2017, the US generic drug market grew at a CAGR of 13% and currently represents a multibillion dollar industry. The biggest catalyst of this industry is the significantly lower price of generics compared to branded drugs. Although generics are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price.

This has enabled governments and third-party payers to save billions of dollars in healthcare expenditures and resulted in lower copayments for patients. Other factors such as patent expiration of blockbuster innovator drugs, ageing population and an increasing prevalence of chronic diseases have also acted as catalysts for this market.

Why is the US Generic Drug Market so Lucrative

  • Patent Expiry of Blockbuster Drugs
  • Significant Price Differential between Generics and Innovator Drugs
  • Savings for the Government and Third Party Payers
  • Incentives for Dispensing and Prescribing Generic Drugs
  • Reimbursement and Lower Copayments
  • Biosimilars

Key Topics Covered:

1 Preface

2 Research Methodology and Market Definitions

3 Executive Summary

4 US Generic Drug Market - Introduction

5 Why is the US Generic Drug Market so Lucrative

6 Global Generic Drug Market

7 US Generic Drug Market

8 US Generic Drug Market - Market Breakup by Segment

9 US Generic Drug Market - SWOT Analysis

10 US Generic Drug Market - Value Chain Analysis

11 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain

12 Porter's Five Forces Analysis

13 US Generic Drug Market- Competitive Landscape

14 Regulations in the US Generic Drug Industry

15 US Generic Drug Market: Key Success Factors

16 US Generic Drug Market: Road Blocks

17 Requirements for Setting Up a Generic Drug Manufacturing Plant

18 US Generic Drug Market - Key Company Profiles

  • Teva
  • Mylan
  • Actavis
  • Sandoz
  • Sun Pharma
  • Par Pharmaceuticals
  • Endo Pharmaceuticals
  • Lupin Pharmaceuticals
  • Dr Reddy's
  • Hospira

For more information about this report visit https://www.researchandmarkets.com/research/3jwxpg/united_states?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Generic Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Generic Drugs